A randomized, double-blind, double-dummy, multicenter trial comparing the efficacy and safety of extended- and immediate-release levetiracetam in people with partial epilepsy

Epilepsy is a serious chronic neurological condition characterized by recurrent seizures, which have significant impacts on both health and quality of life of affected individuals. For people with epilepsy, adherence to antiepileptic drug (AED) regimens is crucial for seizure control and can maximize the quality of life [1]. Nonadherence may result in breakthrough seizures with serious consequences that may also compromise an individual’s perceived quality of life [2].

0